

Dr Antonio Martorell
Dr Antonio Martorell is a dermatologist at the Hospital de Manises in Valencia, Spain, and an Associate Professor of dermatology at the Catholic University of Valencia. He founded and leads a specialised unit focused mainly on the management of patients with psoriasis, hidradenitis suppurativa and related comorbidities.
Dr Martorell received his degree in medicine and surgery from the University of Valencia and specialised in dermatology at Hospital Instituto Valenciano de Oncología, Valencia, an international reference centre in surgery and oncology.
Dr Martorell’s main scientific areas of interest are psoriasis, hidradenitis suppurativa and hair disorders. His recent research has focused on the epigenetic pathways of hidradenitis suppurativa and skin ultrasound, and he is the founder of the DERMUS Task Force. Dr Martorell has authored 217 PubMed articles and has been the invited speaker for 351 lectures covering topics including psoriasis, hidradenitis suppurativa and skin cancer. He is also the Principal Investigator of over 20 clinical assays in phase II, III and IV clinical trials. In addition, Dr Martorell is the founder and coordinator of the Spanish Working Group on Hidradenitis Suppurativa (GTHS), and since 2022, he has led the innovation and research area of the Spanish Academy of Dermatology and Venereology (AEDV). Dr Martorell is also director of the IADERMA course leading a group focused on eHealth oriented to the development of ICT solutions with the aim of improving basic medical procedures during this new technological era. Dr Martorell holds the position of health manager and project coordinator at E-health in SKIANA®.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1

Setting up MDT care in HS: Learning from psoriasis
Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

Use of imaging in HS management
Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

Informed decisions for effective HS management
Different HS phenotypes and disease severity scores: their role in informing management decisions